" class="no-js "lang="en-US"> IDEAYA Biosciences - Medtech Alert
Thursday, August 14, 2025
IDEAYA Biosciences | Pharmtech Focus

IDEAYA Biosciences

About IDEAYA Biosciences

IDEAYA Biosciences

IDEAYA is a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics.  IDEAYA’s approach integrates capabilities in identifying and validating translational biomarkers with drug discovery to select patient populations most likely to benefit from its targeted therapies.  IDEAYA is applying its research and drug discovery capabilities to synthetic lethality – which represents an emerging class of precision medicine targets.

Related Story

IDEAYA Announces First Patient Dosed in Phase 1 Clinical Trial for IDE161 as Potential First-in-Class PARG Inhibitor Targeting HRD Solid Tumors

April 19 2023

IDEAYA Biosciences, a precision medicine oncology company committed to the discovery and development of targeted […]

IDEAYA Biosciences Appoints Darrin M. Beaupre, M.D., Ph.D., as Chief Medical Officer

November 28 2022

IDEAYA Biosciences, a synthetic lethality-focused precision medicine oncology company committed to the discovery and development […]